An algorithm for preventing bypass-associated dilutional (BAD) coagulopathy: Theory and example

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objectives: Crystalloid administered during cardiopulmonary bypass may significantly dilute clotting factor concentrations, particularly in low blood volume patients. Should the administered fluid (pump prime plus IVs) drop the clotting factor concentrations below approximately 38%, almost all patients will bleed, heparin levels will be overestimated and excessive neutralizing protamine will be administered. This combination can render blood virtually unclottable. This paper describes algorithms that quantify dilution risk and the maximum fluid that can be safely administered. A confirmatory calculation to prevent excessive protamine administration is also described. © 2010 Elsevier Inc.

Cite

CITATION STYLE

APA

Herrmann, P. C., Hay, K. L., & Bull, B. S. (2010). An algorithm for preventing bypass-associated dilutional (BAD) coagulopathy: Theory and example. Blood Cells, Molecules, and Diseases, 45(1), 98–101. https://doi.org/10.1016/j.bcmd.2010.03.009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free